Literature DB >> 31919079

Impact of relative dose intensity of standard regimens on survival in elderly patients aged 80 years and older with diffuse large B-cell lymphoma.

Shin Lee1,2, Kei Fujita1, Eiju Negoro3,2, Tetsuji Morishita4,5, Kana Oiwa1, Hikaru Tsukasaki6, Keiichi Kinoshita6, Yasukazu Kawai7, Takanori Ueda1, Takahiro Yamauchi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31919079      PMCID： PMC7395278          DOI： 10.3324/haematol.2019.234435

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma.

Authors:  Tsuneaki Hirakawa; Hiroki Yamaguchi; Norio Yokose; Seiji Gomi; Koiti Inokuchi; Kazuo Dan
Journal:  Ann Hematol       Date:  2010-04-23       Impact factor: 3.673

2.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

3.  CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Authors:  Bertrand Coiffier; Eric Lepage; Josette Briere; Raoul Herbrecht; Hervé Tilly; Reda Bouabdallah; Pierre Morel; Eric Van Den Neste; Gilles Salles; Philippe Gaulard; Felix Reyes; Pierre Lederlin; Christian Gisselbrecht
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

4.  R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.

Authors:  Takeshi Hara; Takeshi Yoshikawa; Hideko Goto; Michio Sawada; Toshiki Yamada; Kenji Fukuno; Senji Kasahara; Yuhei Shibata; Takuro Matsumoto; Ryoko Mabuchi; Nobuhiko Nakamura; Hiroshi Nakamura; Soranobu Ninomiya; Junichi Kitagawa; Nobuhiro Kanemura; Yasuhito Nannya; Naoki Katsumura; Takeshi Takahashi; Yusuke Kito; Tsuyoshi Takami; Tatsuhiko Miyazaki; Tamotsu Takeuchi; Masahito Shimizu; Hisashi Tsurumi
Journal:  Hematol Oncol       Date:  2018-06-08       Impact factor: 5.271

5.  Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.

Authors:  Frédéric Peyrade; Serge Bologna; Vincent Delwail; Jean François Emile; Laurent Pascal; Christophe Fermé; Jean-Marc Schiano; Bertrand Coiffier; Bernadette Corront; Hassan Farhat; Christophe Fruchart; Herve Ghesquieres; Margaret Macro; Hervé Tilly; Bachra Choufi; Richard Delarue; Olivier Fitoussi; Jean Gabarre; Corinne Haioun; Fabrice Jardin
Journal:  Lancet Haematol       Date:  2017-01       Impact factor: 18.959

6.  Population ageing and wellbeing: lessons from Japan's long-term care insurance policy.

Authors:  Nanako Tamiya; Haruko Noguchi; Akihiro Nishi; Michael R Reich; Naoki Ikegami; Hideki Hashimoto; Kenji Shibuya; Ichiro Kawachi; John Creighton Campbell
Journal:  Lancet       Date:  2011-08-30       Impact factor: 79.321

7.  Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

Authors:  Frédéric Peyrade; Fabrice Jardin; Catherine Thieblemont; Antoine Thyss; Jean-François Emile; Sylvie Castaigne; Bertrand Coiffier; Corinne Haioun; Serge Bologna; Olivier Fitoussi; Gérard Lepeu; Christophe Fruchart; Dominique Bordessoule; Michel Blanc; Richard Delarue; Maud Janvier; Bruno Salles; Marc André; Marion Fournier; Philippe Gaulard; Hervé Tilly
Journal:  Lancet Oncol       Date:  2011-04-07       Impact factor: 41.316

8.  Suicidal Ideation and Social Capital: Community Matters.

Authors:  Adam Simning; Yeates Conwell
Journal:  Am J Geriatr Psychiatry       Date:  2016-11-08       Impact factor: 4.105

9.  Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma.

Authors:  Kenneth R Carson; Peter Riedell; Ryan Lynch; Chadi Nabhan; Tanya M Wildes; Weijian Liu; Arun Ganti; Ryan Roop; Kristen M Sanfilippo; Katiuscia O'Brian; Jingxia Liu; Nancy L Bartlett; Amanda Cashen; Nina Wagner-Johnston; Todd A Fehniger; Graham A Colditz
Journal:  J Geriatr Oncol       Date:  2015-01-19       Impact factor: 3.599

10.  Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study.

Authors:  Maja Bech Juul; Pernille Hammershoej Jensen; Henriette Engberg; Sonja Wehberg; Andriette Dessau-Arp; Donika Haziri; Helene Bjoerg Kristensen; Joachim Baech; Lene Schurmann; Michael Roost Clausen; Rebecca Valentin; Lene Meldgaard Knudsen; Lars Munksgaard; Tarec Christoffer El-Galaly; Henrik Frederiksen; Thomas Stauffer Larsen
Journal:  Eur J Cancer       Date:  2018-06-20       Impact factor: 9.162
View more
  5 in total

1.  Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review.

Authors:  Edward J Bataillard; Chan Yoon Cheah; Matthew J Maurer; Arushi Khurana; Toby A Eyre; Tarec Christoffer El-Galaly
Journal:  Blood Adv       Date:  2021-05-11

2.  Utility of the Geriatric 8 for the Prediction of Therapy-Related Toxicity in Older Adults with Diffuse Large B-Cell Lymphoma.

Authors:  Kana Oiwa; Kei Fujita; Shin Lee; Tetsuji Morishita; Hikaru Tsukasaki; Eiju Negoro; Takanori Ueda; Takahiro Yamauchi
Journal:  Oncologist       Date:  2020-12-30

3.  Factors Associated with Discontinuation of Statin Therapy in Patients with Lymphoma Aged 80 Years and Older: A Retrospective Single-Institute Study.

Authors:  Satoshi Yamasaki; Tomotake Tokunou; Takahiko Horiuchi
Journal:  Drugs Real World Outcomes       Date:  2022-06-18

4.  The beneficial effect of Escalated-R-CHOP-21 for the treatment of diffuse large B-cell lymphoma in elderly male patients: A propensity-matched cohort study.

Authors:  Hai-Xia He; Yan Gao; Bing Bai; Xiao-Xiao Wang; Ji-Bin Li; Cheng Huang; Jia-Ying Mao; Li-Qin Ping; Qi-Xiang Rong; Yan-Xia He; He Huang; Qing-Qing Cai; Zhi-Ming Li; Wen-Qi Jiang; Hui-Qiang Huang
Journal:  Cancer Med       Date:  2021-09-28       Impact factor: 4.452

Review 5.  The Impact of Cognitive Impairment on Treatment Toxicity, Treatment Completion, and Survival among Older Adults Receiving Chemotherapy: A Systematic Review.

Authors:  Schroder Sattar; Kristen Haase; Isabel Tejero; Cara Bradley; Caroline Mariano; Heather Kilgour; Ridhi Verma; Eitan Amir; Shabbir Alibhai
Journal:  Cancers (Basel)       Date:  2022-03-21       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.